Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.
Inaguma S, Lasota J, Wang Z, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Miettinen M.
Inaguma S, et al. Among authors: ikeda h.
Hum Pathol. 2018 Jan;71:1-7. doi: 10.1016/j.humpath.2017.04.032. Epub 2017 Aug 12.
Hum Pathol. 2018.
PMID: 28811252
Free PMC article.